Printer Friendly

Eli Lilly and Company signs settlement agreement over generic version of Cialis.

M2 EQUITYBITES-July 14, 2017-Eli Lilly and Company signs settlement agreement over generic version of Cialis

(C)2017 M2 COMMUNICATIONS http://www.m2.com

It was reported on Thursday that US-based Eli Lilly and Company has signed a settlement agreement with companies intending to produce generic versions of the drug Cialis.

The settlement has been signed to resolve pending patent litigation in the United States District Court for the Eastern District of Virginia regarding the Cialis (tadalafil) unit dose patent. This patent was earlier set to expire on 26 April 2020.

Under the contract, Cialis exclusivity is now likely to end at the earliest on 27 September 2018.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jul 14, 2017
Words:118
Previous Article:Atlantic Renewable Energies commissions fifth wind farm in Brazil.
Next Article:Erytech Pharma signs research collaboration with Queen's University in Canada.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters